Abstract Library

#3014 The Number of Positive Nodes Accurately Predicts Recurrence after Distal Pancreatectomy for Nonfunctioning Neuroendocrine Neoplasms

Introduction: The most appropriate staging system of metastatic lymph nodes (N) for resected pancreatic neuroendocrine tumors (PanNETs) remains unclear, especially regarding those resected by distal pancreatectomy (DP).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Guarneri G

Authors: Guarneri G, de Mestier L, Partelli S, Landoni L, Gaujoux S,

Keywords: non-functioning pancreatic neuroendocrine neoplasm, distal pancreatectomy, examined lymph-node,

#2825 Interest of PET-MRI in the Management of GIT NETs

Introduction: Assessment of GIT NET requires different imaging exams including CT, MRI, Scintigraphy. The hybrid PET-CT machine impacted the management of TNEs. The whole body PET-MRI version is available but poorly evaluated.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Tannoury J

Authors: Tannoury J, Mule S, Chayale J, Luciani A, Ette E,

Keywords: PET, MRI, GIT-NET,

#1897 Prognosis of Sporadic Resected Small (≤ 2 cm) Nonfunctional Pancreatic Neuroendocrine Neoplasms - A Multi-Institutional Study

Introduction: Malignant potential of sporadic nonmetastatic nonfunctional pancreatic neuroendocrine tumors (sNF-PNET) is difficult to preoperatively predict

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Sébastien G

Authors: Sallinen V, Le Large T, Tieftrunk E, Galeev S, Kovalenko Z,

Keywords: pancreatic NETs,

#1483 Biomarker and Target Identification in GEP-NET: From in Silico Prediction to Validation on Patient Tissues

Introduction: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of tumors. Somatostatin agonist treatment has a key role in the management of GEP-NET. However, the prognosis of these tumors varies between individuals. There is, therefore, a need to identify novel prognostic and predictive biomarkers of therapeutic efficacy, as well as to propose novel therapeutic strategies.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Tourlet S, Gentien D, Bauchet A, Nicolas A, Blachon J,

Keywords: GPCR, miR,

#1467 iFiT: An Integrative Bioinformatics Platform for Biomarker and Target Discovery. A Case Study in Neuroendocrine Tumors

Introduction: iFiT (Ipsen Focused-on-new bIological enTities and biomarkers) is a Bioinformatics platform integrating systems biology functionalities together with semantic & logic-based artificial intelligence within a high-scale computing environment.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Tourlet S

Authors: Tourlet S, Scaerou F, Martin A, Thiagalingam A, Paty I,

Keywords: Targets iFiT,